AR, the cell cycle, and prostate cancer

The androgen receptor (AR) is a critical effector of prostate cancer development and progression. The dependence of this tumor type on AR activity is exploited in treatment of disseminated prostate cancers, wherein ablation of AR function (achieved either through ligand depletion and/or the use of A...

Descripción completa

Detalles Bibliográficos
Autores principales: Balk, Steven P., Knudsen, Karen E.
Formato: Texto
Lenguaje:English
Publicado: The Nuclear Receptor Signaling Atlas 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254330/
https://www.ncbi.nlm.nih.gov/pubmed/18301781
http://dx.doi.org/10.1621/nrs.06001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254330/
https://www.ncbi.nlm.nih.gov/pubmed/18301781
http://dx.doi.org/10.1621/nrs.06001

Ejemplares similares